Jakafi — Medical Mutual
Another indication cited in the National Comprehensive Cancer Network (NCCN) guidelines as a category 1, 2A, or 2B recommendation
Initial criteria
- Diagnosis documented by prescriber
- Prescribed by or in consultation with a hematologist or oncologist
Approval duration
1 year